Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia

Egerton, Alice, Brugger, Stefan, Raffin, Marie, Barker, Gareth J, Lythgoe, David J, McGuire, Philip K and Stone, James M 2012. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 37 (11) , pp. 2515-2521. 10.1038/npp.2012.113

Full text not available from this repository.

Abstract

Many patients with schizophrenia show a limited symptomatic response to treatment with dopaminergic antipsychotics. This may reflect the additional involvement of non-dopaminergic neurochemical dysfunction in the pathophysiology of the disorder. We tested the hypothesis that brain glutamate levels would differ between patients with first-episode psychosis who were symptomatic compared with those with minimal symptoms following antipsychotic treatment. Proton magnetic resonance spectroscopy (1H-MRS) spectra were acquired at 3 Tesla in the anterior cingulate cortex and left thalamus in 15 patients with first-episode psychosis in symptomatic remission, and 17 patients with first-episode psychosis who were still symptomatic following at least one course of antipsychotic treatment. Metabolite levels were estimated in ratio to creatine (Cr) using LCModel. Levels of glutamate/Cr in the anterior cingulate cortex were significantly higher in patients who were still symptomatic than in those in remission (T(30)=3.02; P=0.005). Across the entire sample, higher levels of glutamate/Cr in the anterior cingulate cortex were associated with a greater severity of negative symptoms (r=0.42; P=0.017) and a lower level of global functioning (r=−0.47; P=0.007). These findings suggest that clinical status following antipsychotic treatment in schizophrenia is linked to glutamate dysfunction. Treatment with compounds acting on the glutamatergic system might therefore be beneficial in patients who respond poorly to dopaminergic antipsychotics.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Psychology
Publisher: Nature Publishing Group: Open Access Hybrid Model Option B
ISSN: 0893-133X
Date of First Compliant Deposit: 24 October 2018
Date of Acceptance: 30 May 2012
Last Modified: 23 Sep 2022 08:27
URI: https://orca.cardiff.ac.uk/id/eprint/116142

Citation Data

Cited 141 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item